STABILITIES OF QUANTITATIVE PLASMA CULTURE FOR HUMAN-IMMUNODEFICIENCY-VIRUS, RNA, AND P24 ANTIGEN FROM SAMPLES COLLECTED IN VACUTAINER CPT AND STANDARD VACUTAINER TUBES

被引:26
作者
MOLE, L
MARGOLIS, D
CARROLL, R
TODD, J
HOLODNIY, M
机构
[1] SYRACUSE RES GRP,SYRACUSE,NY 13207
[2] CHIRON CORP,EMERYVILLE,CA 94608
关键词
D O I
10.1128/JCM.32.9.2212-2215.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We evaluated the stability of human immunodeficiency virus (HIV) load markers from blood samples collected in VACUTAINER CPT or standard VACUTAINER brand tubes using sodium heparin or sodium citrate as anticoagulants. Quantitative plasma culture and p24 antigen concentrations were determined, and HIV RNA levels in plasma were measured by both reverse transcription-PCR-enzyme-linked immunosorbent assay (RT-PCR-ELISA) and branched DNA methods. All tubes were stored at room temperature for analysis at 2, 24, 48, and 72 h after the blood samples were drawn. No difference was seen between tube types with respect to the HIV titer in plasma or the positivity rate for all samples that demonstrated a fall in titer over time. Unbound p24 antigen levels in plasma decreased during the initial 48-h period in both tube types. Immune complex-dissociated p24 antigen levels decreased in CPT tubes but not in standard VACUTAINER tubes. The HIV RNA copy number in plasma measured by RT-PCR-ELISA was stable in most subjects and was significantly higher in CPT tubes than in standard VACUTAINER tubes at 24 and 72 h after the blood samples were drawn. The branched DNA probe assay detected a significant decline in HIV RNA equivalents in plasma over 72 h in both collection tubes, the decline being more dramatic in the standard VACUTAINER tube than the CPT tube. Overall, interday variability suggests that samples collected for a particular assay should be processed at the same time after blood is drawn and that a particular tube type be used throughout a given study.
引用
收藏
页码:2212 / 2215
页数:4
相关论文
共 13 条
[1]   CELL-FREE PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TITER ASSESSED BY CULTURE AND IMMUNOCAPTURE-REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION [J].
COOMBS, RW ;
HENRARD, DR ;
MEHAFFEY, WF ;
GIBSON, J ;
EGGERT, E ;
QUINN, TC ;
PHILLIPS, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) :1980-1986
[2]   USE OF VIROLOGICAL ASSAYS FOR DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN CLINICAL-TRIALS - RECOMMENDATIONS OF THE AIDS CLINICAL-TRIALS GROUP VIROLOGY COMMITTEE [J].
HAMMER, S ;
CRUMPACKER, C ;
DAQUILA, R ;
JACKSON, B ;
LATHEY, J ;
LIVNAT, D ;
REICHELDERFER, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2557-2564
[3]   QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS [J].
HO, DD ;
MOUDGIL, T ;
ALAM, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1621-1625
[4]  
HOLODNIY M, 1994, J ACQ IMMUN DEF SYND, V7, P363
[5]   REDUCTION IN PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS RIBONUCLEIC-ACID AFTER DIDEOXYNUCLEOSIDE THERAPY AS DETERMINED BY THE POLYMERASE CHAIN-REACTION [J].
HOLODNIY, M ;
KATZENSTEIN, DA ;
ISRAELSKI, DM ;
MERIGAN, TC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1755-1759
[6]   VIRICIDAL EFFECT OF POLYMORPHONUCLEAR LEUKOCYTES ON HUMAN IMMUNODEFICIENCY VIRUS-1 - ROLE OF THE MYELOPEROXIDASE SYSTEM [J].
KLEBANOFF, SJ ;
COOMBS, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :2014-2017
[7]   EFFECT OF PLATELET-ASSOCIATED VIRUS ON ASSAYS OF HIV-1 IN PLASMA [J].
LEE, TH ;
STROMBERG, RR ;
HENRARD, D ;
BUSCH, MP .
SCIENCE, 1993, 262 (5139) :1585-1585
[8]   INFECTIOUS DECAY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN PLASMA [J].
MOUDGIL, T ;
DAAR, ES .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :210-212
[9]  
PACHL C, UNPUB
[10]   QUANTITATIVE-EVALUATION OF HEPATITIS-C VIRUS-RNA IN PATIENTS WITH CONCURRENT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS [J].
SHERMAN, KE ;
OBRIEN, J ;
GUTIERREZ, AG ;
HARRISON, S ;
URDEA, M ;
NEUWALD, P ;
WILBER, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2679-2682